Vaxart to Host Virtual Stockholder Fireside Chat on Wednesday, August 20 to Discuss Reverse Stock Split Proposal

Core Viewpoint - Vaxart, Inc. is seeking stockholder support for a reverse stock split proposal, which has been endorsed by leading proxy advisory firms ISS and Glass Lewis [1][3]. Group 1: Company Overview - Vaxart is a clinical-stage biotechnology company focused on developing oral recombinant vaccines using a proprietary delivery platform [5]. - The company's vaccines are designed to be administered in pill form, eliminating the need for refrigeration and reducing the risk of needle-stick injuries [5]. - Current development programs include vaccines targeting coronavirus, norovirus, influenza, and a therapeutic vaccine for human papillomavirus (HPV) [5]. Group 2: Stockholder Engagement - The senior management team will host a virtual stockholder fireside chat on August 20, 2025, to address stockholder questions, particularly regarding the reverse stock split and Nasdaq compliance [2]. - Stockholders of record as of July 29, 2025, are encouraged to vote on the proposal by September 4, 2025 [4]. Group 3: Communication and Support - Investors can submit questions in advance of the conference call via email or through the webcast portal [3]. - A replay of the webcast will be available on the company's website after the event [3].